Effect of Recombinant or Lymphoblastoid Interferon-α on Alanine Aminotransferase in Patients with Chronic Hepatitis C or Chronic Non-A Non-B Hepatitis

Clinical Drug Investigation ◽

10.2165/00044011-199509050-00001 ◽

1995 ◽

Vol 9 (5) ◽

pp. 239-254 ◽

Author(s):

F. Bardelli ◽

A. Messori ◽

R. Rampazzo ◽

A. Alberti ◽

N. Martini

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Alanine Aminotransferase ◽

Interferon Α ◽

Lymphoblastoid Interferon

Download Full-text

Characterization of elevated alanine aminotransferase levels during pegylated-interferon α-2b plus ribavirin treatment for chronic hepatitis C

Hepatology Research ◽

10.1111/j.1872-034x.2010.00749.x ◽

2011 ◽

Vol 41 (2) ◽

pp. 118-125 ◽

Author(s):

Yo-hei Aoki ◽

Shogo Ohkoshi ◽

Satoshi Yamagiwa ◽

Masahiko Yano ◽

Hiromichi Takahashi ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Alanine Aminotransferase ◽

Pegylated Interferon ◽

Download Full-text

Pegylated interferon α-2b plus ribavirin for Japanese chronic hepatitis C patients with normal alanine aminotransferase

Hepatology Research ◽

10.1111/j.1872-034x.2011.00907.x ◽

2011 ◽

Vol 42 (1) ◽

pp. 33-41 ◽

Author(s):

Mosaburo Kainuma ◽

Norihiro Furusyo ◽

Koichi Azuma ◽

Eiji Kajiwara ◽

Kazuhiro Takahashi ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Alanine Aminotransferase ◽

Pegylated Interferon ◽

Interferon Α ◽

Normal Alanine Aminotransferase ◽

Chronic Hepatitis C Patients

Download Full-text

Randomized controlled clinical trial of lymphoblastoid interferon-α for chronic hepatitis C

Hepatology Research ◽

10.1016/s1386-6346(01)00073-0 ◽

2001 ◽

Vol 21 (1) ◽

pp. 55-66 ◽

Author(s):

Y Arase

Keyword(s):

Clinical Trial ◽

Chronic Hepatitis ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Controlled Clinical Trial ◽

Interferon Α ◽

Randomized Controlled Clinical Trial ◽

Randomized Controlled ◽

Lymphoblastoid Interferon

Download Full-text

Randomized controlled trial of lymphoblastoid interferon α for chronic hepatitis C (comparison of 9-MU and 6-MU doses)

The American Journal of Gastroenterology ◽

10.1016/s0002-9270(98)00670-4 ◽

1999 ◽

Vol 94 (1) ◽

pp. 164-168 ◽

Author(s):

K Yoshioka

Keyword(s):

Randomized Controlled Trial ◽

Chronic Hepatitis ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Controlled Trial ◽

Interferon Α ◽

Randomized Controlled ◽

Lymphoblastoid Interferon

Download Full-text

Long-term lymphoblastoid interferon-α therapy for non-cirrhotic chronic hepatitis C: an Italian multicentre study on dose and duration of IFNα treatment

Research in Virology ◽

10.1016/s0923-2516(99)89007-4 ◽

1998 ◽

Vol 149 (5) ◽

pp. 283-291 ◽

Author(s):

F. Piccinino ◽

F.M. Felaco ◽

E. Sagnelli ◽

L. Aprea ◽

V. Messina ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C ◽

Multicentre Study ◽

Chronic Hepatitis C ◽

Interferon Α ◽

Lymphoblastoid Interferon

Download Full-text

Randomized Controlled Trial of Lymphoblastoid Interferon-α for Chronic Hepatitis C; Early Disappearance of HCV RNA is Essential for Sustained Response

HCV and Related Liver Diseases ◽

10.1007/978-4-431-68488-6_7 ◽

1999 ◽

pp. 85-92

Author(s):

Shinichi Kakumu ◽

Keyword(s):

Randomized Controlled Trial ◽

Chronic Hepatitis ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Controlled Trial ◽

Sustained Response ◽

Interferon Α ◽

Hcv Rna ◽

Randomized Controlled ◽

Lymphoblastoid Interferon

Download Full-text

Lymphoblastoid interferon in chronic hepatitis C patients, ‘non-responders’ to recombinant interferon-α (rIFN-α)

Journal of Hepatology ◽

10.1016/0168-8278(92)90205-4 ◽

1992 ◽

Vol 14 (2-3) ◽

pp. 419-420 ◽

Author(s):

Lucia Cimino ◽

Cinzia Citarella ◽

Gerardo Nardone ◽

Gabriele Budillon

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Interferon Α ◽

Recombinant Interferon ◽

Chronic Hepatitis C Patients ◽

Lymphoblastoid Interferon

Download Full-text

Psychiatric side effects during combination treatment for chronic hepatitis C with interferon-α and ribavirin in psychiatric risk groups—A prospective and controlled study

Gastroenterology ◽

10.1016/s0016-5085(01)82831-6 ◽

2001 ◽

Vol 120 (5) ◽

pp. A569-A570

Author(s):

M SCHAEFER ◽

F SCHMIDT ◽

M SOYKA ◽

R LORENZ ◽

K LOESCHKE ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C ◽

Side Effects ◽

Chronic Hepatitis C ◽

Combination Treatment ◽

Risk Groups ◽

Controlled Study ◽

Interferon Α ◽

Psychiatric Side Effects

Download Full-text

Re-treatment virologic response in chronic hepatitis C virologic non-responders (NR) and responder-relapsers (NR) to interferon (IFN) monotherapy: IFN α-2b induction followed by combination ribavirin/interferon α-2b vs combination ribavirin/interferon α-2b (780 MIU/52 weeks rebetron therapy)

Gastroenterology ◽

10.1016/s0016-5085(01)82822-5 ◽

2001 ◽

Vol 120 (5) ◽

pp. A568-A568

Author(s):

N PIMSTONE ◽

J CANIO ◽

M CHIANG ◽

J KOKOSINSKI ◽

J POWELL ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Virologic Response ◽

Download Full-text

Treatment and outcome of genotype 4 chronic hepatitis C patients with pegylated interferon α-2b and ribavirin in a German real-life-setting

Zeitschrift für Gastroenterologie ◽

10.1055/s-0030-1269729 ◽

2011 ◽

Vol 49 (01) ◽

Author(s):

S Mauss ◽

E Zehnter ◽

MP Manns ◽

G Teuber ◽

T Dahhan ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Real Life ◽

Pegylated Interferon ◽

Interferon Α ◽

Real Life Setting ◽

Chronic Hepatitis C Patients

Download Full-text